Poniard Pharmaceuticals Stock Market Value
| PARD Stock | USD 0.0001 0.00 0.00% |
| Symbol | Poniard |
Poniard Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Poniard Pharmaceuticals' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Poniard Pharmaceuticals.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Poniard Pharmaceuticals on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Poniard Pharmaceuticals or generate 0.0% return on investment in Poniard Pharmaceuticals over 90 days. Poniard Pharmaceuticals is related to or competes with Gilead Sciences, Sanofi ADR, Amgen, Merck, and Novo Nordisk. Poniard Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of cancer t... More
Poniard Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Poniard Pharmaceuticals' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Poniard Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
Poniard Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Poniard Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Poniard Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Poniard Pharmaceuticals historical prices to predict the future Poniard Pharmaceuticals' volatility.Poniard Pharmaceuticals Backtested Returns
We have found three technical indicators for Poniard Pharmaceuticals, which you can use to evaluate the volatility of the company. The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Poniard Pharmaceuticals are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Poniard Pharmaceuticals has perfect predictability. Overlapping area represents the amount of predictability between Poniard Pharmaceuticals time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Poniard Pharmaceuticals price movement. The serial correlation of 1.0 indicates that 100.0% of current Poniard Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Poniard Pink Sheet
Poniard Pharmaceuticals financial ratios help investors to determine whether Poniard Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Poniard with respect to the benefits of owning Poniard Pharmaceuticals security.